{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T12:35:55Z","timestamp":1780490155479,"version":"3.54.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Urol\u00f3gicas Espa\u00f1olas"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.acuro.2015.04.001","type":"journal-article","created":{"date-parts":[[2015,5,23]],"date-time":"2015-05-23T02:33:57Z","timestamp":1432348437000},"page":"139-147","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["OnabotulinumtoxinA en vejiga hiperactiva: Recomendaciones de consenso basadas en la evidencia"],"prefix":"10.1016","volume":"40","author":[{"given":"M.A.","family":"Jim\u00e9nez-Cidre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Arlandis-Guzm\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.acuro.2015.04.001_bib0150","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/nau.10052","article-title":"The standardisation of terminology of lower urinary tract function: Report from the Standardisation Sub-committee of the International Continence Society","volume":"21","author":"Abrams","year":"2002","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.acuro.2015.04.001_bib0155","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/01952307.1993.11735903","article-title":"Clinical effect of alpha-1 antagonism by terazosin on external and internal urinary sphincter function","volume":"16","author":"Chancellor","year":"1993","journal-title":"J Am Paraplegia Soc"},{"key":"10.1016\/j.acuro.2015.04.001_bib0160","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S0022-5347(17)32612-5","article-title":"Multicenter trial in North America of UroLume urinary sphincter prosthesis","volume":"152","author":"Chancellor","year":"1994","journal-title":"J Urol"},{"key":"10.1016\/j.acuro.2015.04.001_bib0165","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/nau.1930140106","article-title":"External urethral sphincterotomy: Long-term follow-up","volume":"14","author":"Yang","year":"1995","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.acuro.2015.04.001_bib0170","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.eururo.2013.04.001","article-title":"OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: A randomised, double-blind, placebo-controlled trial","volume":"64","author":"Chapple","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuro.2015.04.001_bib0175","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.eururo.2013.10.033","article-title":"An updated systematic review and statistical comparison of standardised mean outcomes for the use of botulinum toxin in the management of lower urinary tract disorders","volume":"65","author":"Mangera","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuro.2015.04.001_bib0180","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0022-5347(17)42717-0","article-title":"Effects of botulinum A toxin on detrusor-sphincter dyssynergia in spinal cord injury patients","volume":"139","author":"Dykstra","year":"1988","journal-title":"J Urol"},{"key":"10.1016\/j.acuro.2015.04.001_bib0185","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1136\/jnnp.63.4.474","article-title":"Botulinum A toxin as a treatment of detrusorsphincter dyssynergia in patients with spinal cord injury: MRI controlled transperineal injections","volume":"63","author":"Schurch","year":"1997","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.acuro.2015.04.001_bib0190","first-page":"24","article-title":"Treatment of detrusor-sphincter dyssynergia with botulinum A toxin: A double-blind study","volume":"71","author":"Dykstra","year":"1990","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.acuro.2015.04.001_bib0195","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/sj.sc.3100517","article-title":"Botulinum A toxin treatment for detrusor-sphincter dyssynergia in spinal cord disease","volume":"36","author":"Petit","year":"1998","journal-title":"Spinal Cord"},{"key":"10.1016\/j.acuro.2015.04.001_bib0200","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1056\/NEJM200003023420918","article-title":"Treatment of neurogenic incontinence with botulinum toxin A","volume":"342","author":"Schurch","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acuro.2015.04.001_bib0205","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0302-2838(02)00209-9","article-title":"Botulinum a toxin and detrusor sphincter dyssynergia: a double-blind lidocaine-controlled study in 13 patients with spinal cord disease","volume":"42","author":"De Seze","year":"2002","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuro.2015.04.001_bib0210","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.eururo.2003.12.004","article-title":"European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity","volume":"45","author":"Reitz","year":"2004","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuro.2015.04.001_bib0215","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.eururo.2009.04.028","article-title":"EAU guidelines on neurogenic lower urinary tract dysfunction","volume":"56","author":"Stohrer","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuro.2015.04.001_bib0220","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1016\/j.juro.2010.08.021","article-title":"Efficacy and safety of onabotulinumtoxinA for idiopathic overactive bladder: A double-blind, placebo controlled, randomized, dose ranging trial","volume":"184","author":"Dmochowski","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.acuro.2015.04.001_bib0225","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.eururo.2011.10.028","article-title":"Efficacy and safety of low doses of onabotulinumtoxinA for the treatment of refractory idiopathic overactive bladder: A multicentre, double-blind, randomised, placebo-controlled dose-ranging study","volume":"61","author":"Denys","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuro.2015.04.001_bib0230","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.acuro.2013.12.002","article-title":"Expert consensus on scientific evidence available on the use of botulinum toxin in overactive bladder","volume":"38","author":"Esteban","year":"2014","journal-title":"Actas Urol Esp"},{"key":"10.1016\/j.acuro.2015.04.001_bib0235","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/hed.2880120504","article-title":"Botulinum A toxin for the treatment of spasmodic torticollis: Dysphagia and regional toxin spread","volume":"12","author":"Borodic","year":"1990","journal-title":"Head Neck"},{"key":"10.1016\/j.acuro.2015.04.001_bib0240","unstructured":"Ficha t\u00e9cnica de Botox\u00ae. [consultado 12 May 2015]. Disponible en: http:\/\/www.aemps.gob.es"},{"issue":"6 Suppl","key":"10.1016\/j.acuro.2015.04.001_bib0245","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1016\/j.juro.2012.09.079","article-title":"American Urological Association; Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA\/SUFU guideline","volume":"188","author":"Gormley","year":"2012","journal-title":"J Urol"},{"key":"10.1016\/j.acuro.2015.04.001_bib0250","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.acuro.2012.12.001","article-title":"European Association of Urology guidelines on assessment and nonsurgical management of urinary incontinence","volume":"37","author":"Lucas","year":"2013","journal-title":"Actas Urol Esp"},{"key":"10.1016\/j.acuro.2015.04.001_bib0255","first-page":"1202","article-title":"Multiple sclerosis","author":"Nicholas","year":"2012","journal-title":"Clin Evid (Online)"},{"key":"10.1016\/j.acuro.2015.04.001_bib0260","first-page":"1183","article-title":"Botulinum toxin type A in pregnancy","volume":"59","author":"Tan","year":"2013","journal-title":"CanFam Physician"},{"key":"10.1016\/j.acuro.2015.04.001_bib0265","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1016\/j.juro.2012.12.022","article-title":"OnabotulinumtoxinA for the treatment of patients with overactive bladder and urinary incontinence: Results of a phase 3, randomized, placebo controlled trial","volume":"189","author":"Nitti","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.acuro.2015.04.001_bib0270","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.urology.2007.11.039","article-title":"Urodynamic assessment of poor responders after botulinum toxin-A treatment for overactive bladder","volume":"71","author":"Sahai","year":"2008","journal-title":"Urology"},{"key":"10.1016\/j.acuro.2015.04.001_bib0275","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0022-5347(06)00590-8","article-title":"Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics","volume":"176","author":"Schmid","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.acuro.2015.04.001_bib0280","article-title":"The 3-day bladder diary is a feasible, reliable and valid tool to evaluate the lower urinary tract symptoms in women","author":"Jimenez-Cidre","year":"2013","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.acuro.2015.04.001_bib0285","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/nau.10066","article-title":"Good urodynamic practices: Uroflowmetry, filling cystometry, and pressure-flow studies","volume":"21","author":"Sch\u00e4fer","year":"2002","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.acuro.2015.04.001_bib0290","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/j.purol.2013.10.006","article-title":"Guidelines for practical usage of botulinum toxin type A (BoNTA) for refractory idiopathic overactive bladder management","volume":"23","author":"Hermieu","year":"2013","journal-title":"Prog Urol"}],"container-title":["Actas Urol\u00f3gicas Espa\u00f1olas"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210480615001527?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210480615001527?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,25]],"date-time":"2019-08-25T09:18:33Z","timestamp":1566724713000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0210480615001527"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S0210480615001527"],"URL":"https:\/\/doi.org\/10.1016\/j.acuro.2015.04.001","relation":{},"ISSN":["0210-4806"],"issn-type":[{"value":"0210-4806","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"OnabotulinumtoxinA en vejiga hiperactiva: Recomendaciones de consenso basadas en la evidencia","name":"articletitle","label":"Article Title"},{"value":"Actas Urol\u00f3gicas Espa\u00f1olas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acuro.2015.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 AEU. Published by Elsevier Espa\u00f1a, S.L. All rights reserved.","name":"copyright","label":"Copyright"}]}}